Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-19-008782

CEO, Pres, CFO, Treas & Secy bought 25,000 shares at $0.90 ($22,380)

From the SEC's structured data for this filing

Trades in this filing

KENYON LAWRENCE A · CEO, Pres, CFO, Treas & Secy

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-02-07 Purchase : show line 1 in the form +25,000 $0.90 $22,380 82,213 D
Open-market purchases · 25,000 sh · avg $0.90 · $22,380
Loading xslF345X03/doc4.xml…